Austco Healthcare (AHC) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
19 Aug, 2026Executive summary
Achieved record FY25 revenue of $81.4 million, up 40% year-over-year, driven by organic growth and acquisitions.
EBITDA rose 62% to $13.0 million, reflecting strong operational leverage and successful integration of acquired businesses.
Net Profit Before Tax increased to $8.1 million, with balanced earnings across both halves of the year.
Net Profit After Tax was $5.9 million, impacted by a higher tax expense and a one-off contingent consideration expense.
Financial highlights
Gross margin grew 38% to $42.4 million, with margin percentage slightly down to 52.0% due to acquisitions.
Overhead expenses increased to $32.6 million, mainly from integrating three acquired businesses.
Cash on hand at year-end was $14.5 million, up from $13.6 million, supporting further investments without new debt.
Outlook and guidance
Confident in sustaining earnings growth into FY26 and beyond, supported by strong market demand and operational efficiencies.
Latest events from Austco Healthcare
- Record revenue, profit, and recurring software growth, with strong cash and major contract wins.AHC
H2 2026 - Record revenue and profit growth driven by contracts, acquisitions, and software innovation.AHC
Investor presentation - Record revenue, profit, and software growth driven by acquisitions and innovation.AHC
Investor presentation - Record revenue and EBITDA growth, global expansion, and strong cash position drive future outlook.AHC
Investor presentation - Record revenue and profit growth, with strong order backlog and positive growth outlook.AHC
H2 2024 - Record Q1 revenue growth and major contract wins drive strong outlook for continued expansion.AHC
Q1 2025 TU - First-half FY25 revenue and EBITDA are set to surge, boosted by acquisitions and organic growth.AHC
Q2 2025 TU - Record revenue and EBITDA growth, strong profit, and robust order book support future performance.AHC
H1 2025 - Revenue and EBITDA surged year-over-year, with strong cash flow and robust contracted revenue.AHC
Q4 2025 TU